TMO vs. NVS, PFE, ABT, AZN, ABBV, BMY, SNY, MRK, AMGN, and MDT
Should you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Novartis (NVS), Pfizer (PFE), Abbott Laboratories (ABT), AstraZeneca (AZN), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Sanofi (SNY), Merck & Co., Inc. (MRK), Amgen (AMGN), and Medtronic (MDT). These companies are all part of the "medical" sector.
Thermo Fisher Scientific vs.
Thermo Fisher Scientific (NYSE:TMO) and Novartis (NYSE:NVS) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.
Thermo Fisher Scientific received 502 more outperform votes than Novartis when rated by MarketBeat users. Likewise, 81.91% of users gave Thermo Fisher Scientific an outperform vote while only 61.51% of users gave Novartis an outperform vote.
85.9% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 8.1% of Novartis shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 0.0% of Novartis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Thermo Fisher Scientific has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, Novartis has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500.
Novartis has a net margin of 13.78% compared to Thermo Fisher Scientific's net margin of 13.75%. Novartis' return on equity of 23.29% beat Thermo Fisher Scientific's return on equity.
In the previous week, Thermo Fisher Scientific had 3 more articles in the media than Novartis. MarketBeat recorded 15 mentions for Thermo Fisher Scientific and 12 mentions for Novartis. Novartis' average media sentiment score of 0.70 beat Thermo Fisher Scientific's score of 0.00 indicating that Novartis is being referred to more favorably in the news media.
Thermo Fisher Scientific currently has a consensus price target of $631.31, suggesting a potential upside of 21.55%. Novartis has a consensus price target of $82.25, suggesting a potential downside of 15.30%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, equities research analysts clearly believe Thermo Fisher Scientific is more favorable than Novartis.
Thermo Fisher Scientific pays an annual dividend of $1.40 per share and has a dividend yield of 0.3%. Novartis pays an annual dividend of $2.27 per share and has a dividend yield of 2.3%. Thermo Fisher Scientific pays out 9.1% of its earnings in the form of a dividend. Novartis pays out 69.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Novartis has higher revenue and earnings than Thermo Fisher Scientific. Novartis is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.
Summary
Thermo Fisher Scientific beats Novartis on 13 of the 20 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Thermo Fisher Scientific Competitors List
Related Companies and Tools
